The present study was undertaken to examine whether ribozymes cleaving specifically cathepsin L (CL) mRNA are able to decrease the synthesis of CL protease in rheumatoid arthritis synovial fibroblasts (RA-SF) and thereby reduce the invasiveness into cartilage both in vitro and in the SCID mouse coimplantation model of RA. Two different ribozymes that cleave CL mRNA specifically at positions 533 (RzCL533) and 790 (RzCL790) were generated. Using retroviral gene transfer, RA-SF were transduced with the ribozyme constructs or the empty vector. To examine the effect of the ribozymes on the mRNA level, quantitative analysis for CL mRNA was performed using real-time PCR. For evaluation on the protein level, ELISA using specific anti-CL antibodies was performed. In addition, transduced RA-SF were examined in vitro in a three-dimensional destruction assay evaluating their ability to degrade extracellular matrix produced by human chondrocytes. Matrix destruction was monitored by the release of soluble glycosaminoglycans (sGAG). Using the in vivo SCID mouse coimplantation model of RA, RzCL533-transduced RA-SF and control cells were coimplanted with human cartilage for 60 days. After being killed, invasion of RA-SF into the cartilage was evaluated by using a semiquantitative score. Transduction of RA-SF with RzCL533 and RzCL790 ribozymes decreased significantly the expression of CL mRNA to 44% (range 25-62%) and 20% (range 1-43%), respectively, when compared to mocktransduced cells. The protein concentration of CL in the cell culture supernatants of transduced RA-SF was decreased from 16.0 ng/ml in the mock constructs to 4.1 and 8.2 ng/ml (mean), respectively. Using the in vitro cartilage destruction assay, the release of sGAG decreased to 46 and 60%, respectively, after 14 days when compared to mocktransduced cells. In the SCID mouse coimplantation model of RA, RzCL533-transduced RA-SF revealed a significant lower cartilage invasion when compared to mock and untransduced cells. Using retroviral gene transfer, ribozymes cleaving CL mRNA inhibit specifically the synthesis of this matrix-degrading enzyme and reduce cartilage destruction in in vitro and in vivo models. Our study therefore suggests that ribozymes targeting CL could be a novel and efficient tool to inhibit joint destruction in RA.
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Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by a hyperplastic synovial tissue, inflammatory infiltrates, and a progressive destruction of cartilage and bone.
1,2 Synovial macrophages and fibroblasts belong to the key cell types present at the sites of invasion of the hyperplastic synovial tissue into cartilage and bone. 3 Synovial fibroblasts (SF) have been shown to exhibit features of cellular activation 4 reflected by the enhanced expression of proto-oncogenes such as c-ras, c-myc, c-fos. Moreover, in RA-SF alterations in tumorsuppressor genes 5 and enhanced production of effector molecules, that is, proinflammatory cytokines, adhesion molecules 6 and matrix degrading enzymes such as matrix metalloproteinases, 7 members of the plasminogen-plasmin system 8 and cathepsins 9 have been reported. By expression and secretion of matrix-degrading enzymes, SF have been demonstrated to invade and degrade cartilage and bone; 10 however, the functional relevance of cathepsin L (CL) has not been proven so far.
The cysteine proteinase CL cleaves collagens type I, II, IX and XI 11 and certain proteoglycans. 12, 13 It has been shown to be expressed on both the mRNA and on the protein level by synovial macrophages 14 and fibroblasts at sites of invasion into cartilage and bone. 15, 16 Expression of CL as a member of the cysteine proteinase family has also been demonstrated in a variety of malignancies such as gastric cancer or meningioma, in which it is also an indicator of invasiveness. 17, 18 Furthermore, in some disease entities such as squamous cell carcinoma, CL has prognostic significance. 19 Interestingly, CL was found to be upregulated in chondrosarcoma. 20 Taken together, CL appears to play a key role in both benign and malignant diseases associated with matrix degradation and remodeling.
At present, three major strategies exist to inhibit mRNA expression of target molecules: the antigene, the antisense and the ribozyme approach. 21 Antigene (DNA) and antisense (RNA) sequences hybridize to doublestranded DNA or mRNA sense strands and thereby inhibit transcription or translation of the protein, respectively. Ribozymes are short RNA molecules that hybridize to a complementary sequence of RNA and cleave this target sequence catalytically in the absence of proteins. 22 The 'hammerhead' ribozyme element is usually only 30-40 bases long. It is composed of two target recognition arms and a correctly folded catalytic domain. Ribozymes have been developed as tools for gene therapy applications. Although not all parameters critical for efficient intracellular and in vivo ribozyme activity have been explored systematically, it appears that the ribozyme approach is a tool with considerable potential to inhibit gene transcription in terms of both research and therapeutic strategies. The advantages of employing such structurally simple RNA enzymes for in vivo settings are the established techniques for preparation, their specificity in combination with a negligible toxicity and immunogenicity. 22, 23 Based on this background, the rationale for the present study was to inhibit specifically the production of CL by ribozymes in SF in RA and to investigate whether the downregulation could also inhibit matrix degradation in functional assays. For this purpose, two ribozymes cleaving specifically CL at defined loci were generated and cloned into a retroviral vector. RA-SF were transduced with these vectors, and examined for expression of CL on both mRNA and protein levels, as well as cartilage destruction in vitro and in vivo. We could demonstrate that ribozymes cleaving CL mRNA are able to decrease both the synthesis of CL and reduce the invasion of RA-SF into cartilage in vitro and in vivo.
Results

In vitro testing of ribozyme activities
Ribozyme cleavage specificities and efficiencies were tested by in vitro cleavage reactions (Figure 1) . CL target RNA, transcribed in vitro, was cleaved by RzCL533 into the two expected RNA fragments to over 80% within approximately 4 h; more than 95% cleavage was observed after 22 h (Figure 1a) . The antisense control transcript of the same gene was not cleaved under otherwise identical conditions (data not shown). A clear dose dependence on Mg 2 þ ions was observed, supporting the hammerhead cleavage mechanism, and also showing that even at much lower intracellular concentrations of a few millimolar, cleavage activity was still possible (Figure 1b) . Similarly, RzCL790 cleaved with the same specificity and, although slightly slower, cleavage rates (data not shown). Incubation of CL target RNA under identical cleavage reaction conditions without the ribozyme added did not result in production of any bands similar to the cleavage products, although by 22 h of incubation there was partial random nonspecific degradation of the target RNA (Figure 1c ).
CL mRNA expression in ribozyme-transduced RA-SF To show the higher expression of cathepsin L in RA-SF in comparison to normal fibroblasts, (mock-transduced) RA-SF and NHDF-C cells (immortalized cell line of normal fibroblasts) were measured quantitatively immediately after successful transduction using real-time PCR (TaqMan s ). A 2.2-fold and a 5.7-fold higher expression, were found in the two RA-SF samples when compared to NHDF-C cells, respectively (data not shown). At 2 weeks after retroviral transduction of RA-SF with two ribozymes cleaving the CL mRNA at position 533 or 790, respectively, the expression of CL mRNA was measured using real-time PCR. Levels of CL mRNA in RzCL533-and RzCL790-transduced RA-SF were decreased to 44719% (mean7s.d.; range 25-62%) and 20721% (mean7s.d.; range 1-43%), respectively, in comparison to the mock-transduced RA-SF (both P ¼ 0.037, Mann-Whitney U test; Figure 2 ).
CL protein concentration in ribozyme-transduced RA-SF
To evaluate CL protein levels in RA-SF, the concentration of CL in supernatants of RzCL533-and RzCL790-transduced RA-SF 14 days after successful transduction was measured using a CL-specific ELISA. CL was decreased to 4.52 ng/ml (mean70.81 ng/ml) and 8.22 ng/ml (mean710.42 ng/ml) in comparison to 13.15 ng/ml (mean710.52 ng/ml) in the mock-constructs ( Figure 3a) . To evaluate the duration of time of the ribozyme effect on CL concentration in cellular supernatants in vivo, two samples of RA-SF and one sample of NHDF-C were transduced with the riboyzme and mock control. It could be demonstrated that over a period of at least 8 weeks, the reducing effect of ribozyme RzCL533 on the concentration of CL protein measured in cell supernatants was maintained (Figure 3b ).
Reduction of cartilage degradation in vitro
In the next step, we investigated the functional impact of ribozyme-transduction on RA-SF. Using the in vitro cartilage destruction assay in which chondrocytes had produced a cartilage-like extracellular matrix, the release of soluble glycosaminoglycans (sGAG) was determined. In RzCL533-and RzCL790-transduced RA-SF, the sGAG concentration was decreased to 46 and 60% of the release by mock-transduced cells after 14 days, which leveled out after 21 and 28 days, respectively ( Figure 4 ).
Reduction of cartilage invasion in vivo
The functional relevance of the inhibition of CL by gene transfer utilizing ribozymes was tested in the severe combined immunodeficiency (SCID) mouse coimplantation model of RA. As shown in previous studies, 24 CL ribozymes decrease cartilage destruction in RA J Schedel et al untransduced and mock-transduced RA-SF invaded significantly stronger into the coimplanted cartilage (invasion score 2.7570.31 and 2.8070.58, respectively) than normal synovial fibroblasts (N-SF) (1.0870.24; P ¼ 0.027 for both; see also Figure 5 ). In terms of invasiveness, no differences were found between untransduced RA-SF and mock-transduced RA-SF (P ¼ 0.93) indicating that transduction with the empty vector did not alter the invasive properties of RA-SF. Intriguingly, also no statistical differences with respect to cartilage invasion were detected between N-SF and the ribozyme-treated RA-SF (P ¼ 0.24). RzCL533-transduced RA-SF ( Figure 5B , c and d) revealed a considerably lower cartilage invasiveness than the mock-transduced cells ( Figure 5B, b), but this difference did not reach statistical significance due to one mock control RA-SF sample not exhibiting any relevant invasion (P ¼ 0.126). However, when the mock-transduced and untransduced RA-SF were pooled as control cells with pronounced cartilage invasion and identical invasion scores, the reduction of invasiveness in the ribozyme-transduced cells became CL ribozymes decrease cartilage destruction in RA J Schedel et al significant (P ¼ 0.027). Taken together, these data demonstrate that inhibition of CL by gene transfer with riboyzmes effectively inhibited cartilage destruction in vivo.
Discussion
In RA, matrix metalloproteinases and cathepsins have been shown to drive matrix degradation, especially cartilage and bone destruction, finally resulting in articular destruction of the affected joints. Among the cathepsins, CL is known to degrade various types of collagen and proteoglycans, 11 which are essential components of articular cartilage. CL is expressed by RA-SF and has been demonstrated at the site of invasion of the hyperplastic synovial tissue into cartilage and bone. 15 However, the functional impact of CL in cartilage destruction has not been proven so far.
During the last decade, gene transfer methods have become effective tools to modulate gene expression. Moreover, the possibility to influence disease-specific mechanisms in vivo and to test their functional relevance has met increasing clinical interest, especially in RA. 25 Along this line, it is noteworthy to mention the first phase I clinical trial evaluating the feasibility and safety of an ex vivo gene transfer of an IL-1 receptor antagonist cDNA to the metacarpophalangeal joints of RA patients, 26, 27 two follow-up phase II studies, and more ex vivo studies to come. 28 The rationale for the present study was to inhibit specifically the production of CL by SF and to investigate whether this downregulation could also inhibit matrix degradation in functional assays. For this purpose, two ribozymes cleaving specifically CL at defined loci were generated and cloned into the retroviral vector pLNSX. Our results demonstrate that ribozymes cleaving CL mRNA are able to decrease specifically both the synthesis of CL and its effector pathways, that is, the invasion of RA-SF into cartilage in vitro and cartilage destruction in vivo as shown in the SCID mouse coimplantation model of RA. These data support the concept that CL is of functional relevance in the cartilage destructive pathways of RA. Moreover, it has been shown that gene transfer of ribozymes is feasible.
In line with our data, Perlman et al 29 successfully used a ribozyme cleaving Bcl-2 in SF resulting in reduced cell viability. Specifically, in this study, apoptosis was induced as shown by increased mitochondrial permeability transition, cytochrome c release, and, consecutively, activation of caspase-3 and -9, resulting in DNA fragmentation. 29 In our study, however, the efficacy of ribozymes has not been shown only in vitro, but, intriguingly, also in vivo in the severe combined immunodeficiency (SCID) mouse coimplantation model of RA for an extended period of 60 days. Therefore, one might anticipate that ribozymes targeting CL could present a novel therapeutic tool to target joint destruction in RA.
Just recently, it was shown that adenoviral gene transfer of tissue inhibitors of matrix metalloproteinases (TIMP)-1 and TIMP-3 inhibiting MMPs reduced significantly, but not completely, cartilage invasion of RA-SF in the SCID mouse model. 30 In the present study, gene transfer of ribozymes targeting CL also did not completely block cartilage destruction of RA-SF. Therefore, it appears to be evident that the cartilage destructive pathways are not dependent on one executing pathway, but on different matrix degrading enzymes acting in concert. Accordingly, targeting two different effector pathways using double gene transfer, for example, of 
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After successful transduction RA-SF (n ¼ 2) and NHDF-C (n ¼ 1) cells were cultured over at least 8 weeks; every 2 weeks, the cellular supernatants were collected and measured for CL using an ELISA. Over a period of at least 8 weeks, the reducing effect of ribozyme RzCL533 on CL concentration as measured in cellular supernatants of RA-SF (one representative sample is shown) and NHDF-C samples could be maintained. Owing to the different cell numbers, the protein concentrations were adjusted to 100 000 cells, and are given as percentage of the concentrations of the respective mock-transduced cells.
CL ribozymes decrease cartilage destruction in RA J Schedel et al
TIMPs and ribozymes targeting CL, could be a promising approach. Underlining this concept, double gene transfer of interleukin-1 receptor antagonist (IL-1Ra) and IL-10 has been demonstrated to inhibit both cartilage invasion and the perichondrocytic cartilage degradation in the SCID mouse model of RA. 31 In line with our results targeting CL, in malignant cell lines, it could be shown that cDNA fragments inserted in antisense direction into an expression vector reduced both the mRNA levels and the enzymatic activity of CL in vitro. Of interest, the transduced cells showed also a decreased potential for tumor growth in Balb/c mice in vivo. 32 Accordingly, using antisense oligonucleotides to CL, Krueger et al 33 demonstrated that both mRNA and protein levels could be reduced in an osteosarcoma cell line. In addition, motility and invasive properties of transduced cells were blocked significantly in this study. Furthermore, using a hammerhead ribozyme, Kitajima et al 34 could show that ribozyme-induced ablation of HTLV-I tax/rex mRNA in synovial cells in HTLV-associated chronic arthritis inhibited Tax synthesis, which resulted in inhibition of synovial cell growth and induced apoptosis. All these results suggest that targeting a single molecule with defined function in the pathogenesis of a disease is a potent tool of modulating diseasespecific pathways. Studies using ribozymes to target hepatitis C virus (HCV) mRNA in hepatitis C in vivo are also encouraging. 35 Here, ribozymes were capable of reducing the viral load of HCV significantly. Moreover, combination of interferon-g as standard therapy of hepatitis C and the ribozyme targeting HCV resulted in a significant reduction of viral replication. 36 In this regard, it is of interest that at present, a ribozyme-phase II study in patients with hepatitis C is being performed.
In conclusion, retroviral gene transfer of ribozymes cleaving CL mRNA appears to be a feasible approach to inhibit specifically the synthesis of this catabolic enzyme. Moreover, our study supports the idea that ribozymes against cathepsins might present a novel and efficient tool to inhibit cartilage destruction in RA. CL ribozymes decrease cartilage destruction in RA J Schedel et al
Materials and methods
Patients and tissue preparation
Synovial tissue samples were obtained during synovectomy and arthroplastic surgery from three patients with RA and one trauma patient (Department of Orthopedic Surgery, Schulthess Hospital, Zurich, Switzerland). All RA patients fulfilled the American College of Rheumatology 1987 criteria for the diagnosis of RA. 37 The synovial specimens were fixed in 4% buffered formalin for 4-12 h, decalcified subsequently in 10% EDTA and embedded in paraffin.
Cell culture and RNA isolation
Synovial tissue was minced, washed extensively in sterile PBS and digested with Dispase II (Boehringer Mannheim, Germany) for 1 h at 371C under continuous agitation. The resulting cell suspension was seeded into tissue culture dishes and the released cells cultured in Dulbecco's modified Eagle's medium (Gibco Life Technologies, Basel, Switzerland) containing 10% fetal calf serum at 371C in a humidified atmosphere containing 5% CO 2 . In all experiments, RA-SF were used in passages 3 and 4 only, and N-SF in passage 6. Total RNA was isolated from SF according to the TRIzol s protocol (Gibco Life Technologies).
Preparation of ribozymes and target RNAs
Custom-synthesized DNA oligonucleotides coding for ribozymes were cloned into the T7/T3 transcription vector pBlueScript-SKII. GUX cleavage sites were chosen based on sequence criteria 38, 39 and mRNA folding patterns determined with the Mfold RNA modeling program. 40 As target RNA, a 797 bp fragment from the human CL cDNA, clone phCL-800, 41 also cloned into pBlueScript-SKII, was used. In vitro transcription reactions for the preparation of ribozyme and target RNAs were performed with AmpliScribe T7 or T3 transcription kits (Epicentre, Madison, WI, USA). The corresponding target antisense transcript was used as control for specificity. RNA concentrations were determined by UV spectroscopy, and the integrity of products confirmed by 5% polyacrylamide/7 M urea gel electrophoresis.
Ribozyme cleavage reactions in vitro
Reactions for in vitro cleavage efficiencies were performed in 50 mM Tris-HCl, 1 mM EDTA, 50 mM NaCl, pH 7.5. (1 Â Rz-buffer) at 371C for time periods up to 22 h. Magnesium chloride was added at concentrations of 20, 10, 5, or 1.5 mM; thus, the effective concentrations were 19, 9, 4, or 0.5 mM. A ribozyme:target molar ratio of 10:1 was used to ensure pseudo-first-order reaction conditions. The ribozyme and target RNAs were combined, preheated to 801C for 2 min, and slowly cooled to 371C for unfolding and annealing. Prewarmed MgCl 2 stock aliquots were then added to initiate the cleavage reaction. Time points (5 ml aliquots) were taken and stopped with 1 volume of loading dye on ice (90% formamide, 50 mM EDTA, and 0.25% tracking dyes). Reaction products were analyzed by electrophoresis in 5% polyacrylamide/7 M urea gels run in 1 Â TBE at 100 V for 1.2 h. Gels were stained with ethidium bromide, destained extensively with several changes of water, and photographed with a Polaroid type 55 positive/negative film. Incubation of CL target RNA without addition of the respective ribozyme under otherwise identical conditions was performed as negative control to demonstrate the absence of cleavagespecific bands in the absence of ribozyme; this gel pair was scanned with a Typhoon 9400 Variable Mode Imager system (Amersham Biosciences).
Quantification of cleavage efficacy
Cleavage efficiencies (in %) were determined by measuring the band intensities for uncleaved substrate and cleavage products by densitometry and quantification with the DeskScan II and ImageQuant 1.6. programs. The % cleavage at each time point was calculated as % ¼ (TÀP s )/T Â 100 (with T ¼ P s þ P 1 þ P 2 ; and P s , P 1 , and P 2 ¼ peak intensities of the substrate and the two product bands, respectively).
Generation of ribozymes and retroviral gene transfer
Two ribozymes were designed, which specifically cleave CL at positions 533 (RzCL533) and 790 (RzCL790) of the published gene sequence (GenBank Accession Number M20496). They were produced by deoxyoligonucleotide synthesis, cloning, and in vitro transcription reaction with a T7/T3 RNA polymerase system. Both ribozymes were inserted into tRNA expression cassettes and cloned into the retroviral pLNSX vector.
Pt67 packaging cells were transfected with the constructs, and following selection with activated genicitin (G418), individual clones were obtained by limiting dilution. High producer packaging cells were identified by transduction of RA-SF with a dilution series of the respective supernatants and subsequent selection using G418. Subsequently, subconfluent RA-SF were transduced with supernatants containing ribozyme constructs or the empty vector ( ¼ mock) as control. RA-SF stably expressing RzCL533 and RzCL790 were obtained by selection with G418, cultured under standard culture conditions as outlined above and used for further experiments.
Time-dependent expression of ribozymes targeting CL in RA-SF
To investigate the duration of expression of RzCL533 and its effect on CL concentration, two samples of RA-SF and an immortalized normal fibroblast line (NHDF-C; PromoCell, Heidelberg, Germany) were stably transduced with RzCL533 and mock control vector and cultured over a time of at least 8 weeks. After successful transduction and standard culture conditions, cells were split at 80% confluency. Every 2 weeks, cell culture supernatants were recovered and stored at À201C for further evaluation. In addition, the cells were trypsinized and counted, and, subsequently, reseeded in cell culture plates for further cell culture.
Quantitative mRNA measurement using real-time PCR
To examine the effect of the ribozymes on CL mRNA synthesis, quantitative analysis was performed using real-time PCR (TaqMan s Rotkreuz, Switzerland). The mRNA from successfully transduced RA-SF from three RA patients was isolated according to the TRIzol s protocol. In addition, CL mRNA expression of transduced RA-SF was compared to the mRNA of NHDF-C cells immediately after successful transduction to CL ribozymes decrease cartilage destruction in RA J Schedel et al document the initially different levels of CL expression. Reverse transcription was performed using random hexamers and the MultiScribe reverse transcriptase (PE Applied Biosystems, Rotkreuz, Switzerland) using the following conditions: initially, polymerase activation at 951C for 10 min, subsequently, 40 cycles with denaturation at 951C for 15 s and annealing/extending at 601C for 1 min. The expression level of CL mRNA was determined using a fluorogenic 5 0 nuclease assay according to the TaqMan s assay conditions (PE Applied Biosystems). The TaqMan s primers and probe sequences were as follows: upper primer 5 0 -GAG GCA ACA GAA GAA TCC TGT AAG T-3 0 , lower primer 5 0 -AGG GCC TTC TCC TGC TTA GG-3 0 , probe 5 0 -AGT ATT CTG TTG CTA ATG ACA CCG GCT-3 0 . The PCR was performed on an ABI Prism 7700 Sequence Detection system (PE Applied Biosystems). CL expression was determined relative to the 18S rRNA that was coamplified as an internal standard.
Enzyme-linked immunosorbent assay (ELISA)
For evaluation of the protein levels of CL after transduction of RA-SF from three patients with the two ribozymes, unconcentrated conditioned media from cell culture supernatants were measured 14 days after successful transduction using an ELISA (KRKA Novo Mesto, Slovenia) with specific anti-CL antibodies according to the manufacturer's protocol. Samples were measured in duplicate. To investigate protein levels in cell supernatants of RA-SF and NHDF-C cells over time, protein in conditioned media was measured after 2, 4, 6 and 8 weeks using an alternative ELISA (MedSystems, Vienna, Austria) with specific anti-CL antibodies according to the manufacturer's protocol. Owing to the different numbers of cells, the concentrations were adjusted to 100 000 cells, and are given as percentage of the CL concentration of mock-transduced cells.
In vitro cartilage destruction model
Transduced RA-SF were examined in vitro using a threedimensional destruction assay established recently 42 that evaluates their ability to degrade extracellular matrix produced by human articular chondrocytes. Normal human cartilage was obtained from patients undergoing arthroplastic surgery (Department of Surgery, University Hospital, Zurich). Articular cartilage was cut into small pieces and digested enzymatically using pronase and collagenase P. Isolated chondrocytes were enclosed in an inert collagen sponge soaked with 1% native extracellular matrix obtained from bovine placenta. The sponges were cultured in 24-well plates with 2 ml of DMEM/F-12 medium containing 20% fetal calf serum (FCS), 50 U/ml penicillin-streptomycin and 2.5 mg/ml amphotericin B (Fungizone, Gibco BRL, Grand Island, NY, USA). In these sponges, the chondrocytes produced an extracellular cartilage-like matrix. After 20 days, RzCL533-, RzCL790-and mock-transduced RA-SF (one patient with RA) were added to the chondrocyte sponges, and cocultured for up to 28 days. DMEM/F-12 medium containing 10% FCS, 5 IU/ml penicillin-streptomycin and 0.25 mg/ml amphotericin B was changed daily, and the conditioned media stored at À201C until further examination. Matrix destruction mediated by RA-SF was monitored by the release of soluble glycosaminoglycans (sGAG), which was measured in the collected supernatants using a commercially available ELISA.
SCID mouse model of RA
Using the in vivo SCID mouse coimplantation model of RA, RzCL533 (n ¼ 6), mock (n ¼ 5) transduced RA-SF (from one patient with RA), untransduced RA-SF (n ¼ 6) and N-SF (n ¼ 6) were coimplanted with human cartilage under the renal capsule for 60 days. 24 . In brief, 14-weekold SCID (severe combined immunodeficiency) mice were obtained from a germ-free breeding colony (Charles River, Sulzfeld, Germany) and examined for macroscopic anomalies before and during surgery as well as for macro-and histopathologic abnormalities after killing. At the day of implantation, normal human cartilage was obtained from nonarthritic knee joints of patients undergoing routine surgery at the Department of Orthopedic Surgery (Schulthess Hospital Zurich/ Switzerland). Implantation of fibroblasts and cartilage was performed under sterile conditions using standard procedures. In brief, a cube-like piece of inert collagen sponge (Gelfoam, Pharmacia, Dü bendorf, Switzerland) was incised and a piece of cartilage (approximately 5-8 mm 3 ) was inserted into its center. Thereafter, the sponge was soaked in fibroblasts (B5 Â 10 5 cells) suspended in sterile saline. Subsequently, mice were anesthetized, a small incision was made in the left flank and the kidney was partly exteriorized. Then, the renal capsule was incised and cartilage and fibroblast-containing sponge were engrafted side by side under the renal capsule. After 60 days, the mice were killed, the implants were removed, fixed in 4% buffered formalin and embedded into paraffin according to standard procedures.
Histological evaluation
After the killing, invasion of RA-SF into the cartilage was evaluated by using a semiquantitative score. In brief, the following grading was used: 0: no invasion of synovial cells into the cartilage; 0.5: invasion of 1-2 cell layers; 1: invasion of 3-5 cell layers; 1.5. invasion of 3-5 cell layers at three or more sites; 2: invasion of 6-10 cell layers; 2.5: invasion of 6-10 cell layers at three or more sites; 3: invasion of 11 or more cell layers at one site; 3.5: invasion of 11 or more cell layers at two sites; 4. invasion of 11 or more cell layers at three or more sites.
Statistical analysis
Data were analyzed using a nonparametric test for independent variables (Mann-Whitney U test) within the Statistical Package for the social Sciences software (SPSS, version 10.0). P-values of less than 0.05 were considered significant.
